Back to Search
Start Over
Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry
- Source :
- Komajda, M, Schöpe, J, Wagenpfeil, S, Tavazzi, L, Böhm, M, Ponikowski, P, Anker, S D, Filippatos, G S, Cowie, M R & QUALIFY Investigators 2019, ' Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction : the QUALIFY international registry ', European Journal of Heart Failure, vol. 21, no. 7, pp. 921-929 . https://doi.org/10.1002/ejhf.1459
- Publication Year :
- 2018
-
Abstract
- Background Physicians’ adherence to guideline-recommended therapy is associated with short-term clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF). However, its impact on longer-term outcomes is poorly documented. In this analysis we assessed the longer-term association of physicians’ adherence with clinical outcomes, including mortality and unplanned hospitalisations, at 18-month follow-up of the QUALIFY registry (Clinical trial registration ISRCTN87465420) Method and results Data at 18 months were available for 6118 ambulatory HFrEF patients from this international prospective observational survey. Adherence was measured as a continuous variable, ranging from 0 to 1, and was assessed with regard to five classes of recommended HF medications and dosages. Most deaths were cardiovascular (CV) (228/394) and HF-related (191/394) and the same was true for unplanned hospitalisations (1175 CV and 861 HF-related hospitalisations, out of a total of 1541). According to univariable analysis, CV and HF deaths were significantly associated with physician adherence to guidelines. In multivariable analysis, HF death was associated with adherence level [subdistribution hazard ratio (SHR) 0.93, 95% confidence interval (CI) 0.87–0.99 per 0.1 unit adherence level increase; P = 0.034] as was composite of HF hospitalisation or CV death (SHR 0.97, 95% CI 0.94–0.99 per 0.1 unit adherence level increase; P = 0.043), whereas unplanned all-cause, CV or HF hospitalisations were not (all-cause: SHR 0.99, 95% CI 0.9–1.02; CV: SHR 0.98, 95% CI 0.96–1.01; and HF: SHR 0.99, 95% CI 0.96–1.02 per 0.1 unit change in adherence score; P = 0.52, P = 0.2, and P = 0.4, respectively). Conclusion These results suggest that physicians’ adherence to guideline-recommended HF therapies is associated with improved outcomes in HFrEF. Practical strategies should be established to improve physicians’ adherence to guidelines.
- Subjects :
- Male
medicine.medical_specialty
Dose
Medication Therapy Management
Heart failure
Outcomes
030204 cardiovascular system & hematology
Guidelines
Medication
03 medical and health sciences
0302 clinical medicine
Dosage
Internal medicine
Medication therapy management
Outcome Assessment, Health Care
Outpatients
medicine
Humans
Registries
Practice Patterns, Physicians'
Heart Failure
Ejection fraction
Guideline adherence
business.industry
Cardiovascular Agents
Stroke Volume
Stroke volume
Middle Aged
medicine.disease
Quality Improvement
Confidence interval
Clinical trial
Hospitalization
Adherence
Cardiovascular agent
Ambulatory
Practice Guidelines as Topic
Observational study
Female
Guideline Adherence
Cardiology and Cardiovascular Medicine
business
Follow-Up Studies
Subjects
Details
- ISSN :
- 18790844
- Volume :
- 21
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- European journal of heart failure
- Accession number :
- edsair.doi.dedup.....3a8584353e5f6600a517294bd4520dc0